JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3576
CALL
Carvana
CVNA
$45.6B
| $1.51M | ﹤0.01% |
774,000
-1,031,500
| -57% | -$1.79M |
2019 Q1
16 quarters
|
|
3577
WisdomTree International Equity Fund
DWM
$647M
| $1.51M | ﹤0.01% |
30,425
+2,953
| +11% | +$146K |
2022 Q2
3 quarters
|
|
3578
Oaktree Specialty Lending
OCSL
$1.03B
| $1.51M | ﹤0.01% |
80,503
+70,535
| +708% | +$1.4M |
2022 Q3
2 quarters
|
|
3579
PUT
Skyworks Solutions
SWKS
$12.4B
| $1.51M | ﹤0.01% |
12,800
-67,900
| -84% | -$7.52M |
2021 Q3
6 quarters
|
|
3580
Martin Midstream Partners
MMLP
$69.6M
| $1.51M | ﹤0.01% |
550,873
-30,030
| -5% | -$85.9K |
2021 Q1
8 quarters
|
|
3581
Haleon
HLN
$39.8B
| $1.51M | ﹤0.01% |
185,307
+69,706
| +60% | +$556K |
2022 Q3
2 quarters
|
|
3582
PUT
Teradyne
TER
$63.8B
| $1.5M | ﹤0.01% |
+14,000
| New | +$1.43M |
2023 Q1
0 quarters
|
|
3583
Pegasystems
PEGA
$5.71B
| $1.5M | ﹤0.01% |
62,052
-157,218
| -72% | -$3.31M |
2013 Q2
39 quarters
|
|
3584
CALL
Alnylam Pharmaceuticals
ALNY
$30.3B
| $1.5M | ﹤0.01% |
+7,500
| New | +$1.58M |
2023 Q1
0 quarters
|
|
3585
Quanterix
QTRX
$161M
| $1.5M | ﹤0.01% |
133,240
-8,811
| -6% | -$113K |
2018 Q1
20 quarters
|
|
3586
CALL
Legend Biotech
LEGN
$3.71B
| $1.5M | ﹤0.01% |
31,000
-171,000
| -85% | -$8.36M |
2022 Q1
4 quarters
|
|
3587
Titan International
TWI
$437M
| $1.5M | ﹤0.01% |
142,609
+97,268
| +215% | +$1.38M |
2021 Q2
7 quarters
|
|
3588
SandRidge Energy
SD
$509M
| $1.49M | ﹤0.01% |
103,659
+16,608
| +19% | +$254K |
2016 Q4
25 quarters
|
|
3589
RCI Hospitality Holdings
RICK
$201M
| $1.49M | ﹤0.01% |
19,051
+1,287
| +7% | +$112K |
2016 Q1
28 quarters
|
|
3590
PUT
Teladoc Health
TDOC
$1.02B
| $1.48M | ﹤0.01% |
57,300
-27,400
| -32% | -$733K |
2022 Q4
1 quarter
|
|
3591
Milestone Pharmaceuticals
MIST
$94.6M
| $1.48M | ﹤0.01% |
376,054
+46,330
| +14% | +$169K |
2021 Q4
5 quarters
|
|
3592
JPMorgan US Value Factor ETF
JVAL
$1B
| $1.48M | ﹤0.01% |
43,374
+15,017
| +53% | +$516K |
2022 Q4
1 quarter
|
|
3593
Napco Security Technologies
NSSC
$1.26B
| $1.48M | ﹤0.01% |
39,300
+2,310
| +6% | +$73.6K |
2017 Q4
21 quarters
|
|
|
TGI
3594
DELISTED
Triumph Group
TGI
| $1.48M | ﹤0.01% |
127,413
+61,284
| +93% | +$698K |
2013 Q2
39 quarters
|
|
|
CELL
3595
DELISTED
PhenomeX Inc. Common Stock
CELL
| $1.48M | ﹤0.01% |
1,273,536
-118,259
| -8% | -$216K |
2020 Q3
10 quarters
|
|
3596
Lyell Immunopharma
LYEL
$209M
| $1.48M | ﹤0.01% |
31,250
+2,643
| +9% | +$141K |
2021 Q3
6 quarters
|
|
3597
Sasol
SSL
$9.14B
| $1.48M | ﹤0.01% |
108,051
+103,228
| +2,140% | +$1.6M |
2022 Q3
2 quarters
|
|
3598
PUT
Dollar General
DG
$27.3B
| $1.47M | ﹤0.01% |
7,000
-25,700
| -79% | -$5.77M |
2021 Q2
7 quarters
|
|
|
CLDT
3599
Chatham Lodging
CLDT
$636M
| $1.47M | ﹤0.01% |
140,301
+22,197
| +19% | +$271K |
2013 Q2
39 quarters
|
|
3600
PUT
NextEra Energy
NEE
$161B
| $1.47M | ﹤0.01% |
19,100
-55,200
| -74% | -$4.25M |
2017 Q1
24 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.